Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?

Overview RevenueFinancials Chart Transcripts

Takeda Pharmaceutical Ownership Summary

Takeda Pharmaceutical is owned by 4.79% institutional investors, 0.01% insiders, and 95.20% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.84% of TAK shares. American Funds American Mutual A is the top mutual fund, with 0.41% of its assets in Takeda Pharmaceutical shares.

TAK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Takeda Pharmaceutical	4.79%	0.01%	95.20%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Specialty & Generic Drug Manufacturers Stocks	34.23%	10.67%	55.10%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Capital research global investors	13.13M	0.84%	$169.86M
Mondrian investment partners	7.74M	0.49%	$108.34M
Morgan stanley	4.99M	0.32%	$64.53M
Millennium management	4.35M	0.28%	$56.24M
Goldman sachs group	3.72M	0.24%	$48.10M
Renaissance	2.95M	0.19%	$38.24M
Brandes investment partners, lp	2.64M	0.17%	$34.05M
Fmr	2.62M	0.17%	$33.94M
Arrowstreet capital, limited partnership	2.32M	0.15%	$29.96M
Van eck associates	2.21M	0.14%	$29.27M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Managed asset portfolios	1.61M	3.10%	$20.88M
Mondrian investment partners	7.74M	1.67%	$108.34M
Clean yield group	360.09K	1.52%	$4.77M
Xy capital	162.70K	1.04%	$2.15M
Legacy wealth asset management	140.84K	0.51%	$1.86M
Causeway capital management	1.35M	0.48%	$17.52M
Brandes investment partners, lp	2.64M	0.42%	$34.05M
Gold investment management	71.78K	0.39%	$928.78K
Summit global investments	223.41K	0.20%	$2.89M
Cowen and company	530.60K	0.19%	$6.87M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	4.35M	0.03%	2.02M
Arrowstreet capital, limited partnership	2.32M	0.03%	950.59K
Cowen and company	530.60K	0.19%	530.60K
Hudson bay capital management lp	350.00K	0.02%	175.00K
Crossmark global	210.48K	0.05%	155.79K

Top Sellers

Holder	Shares	% Assets	Change
Mondrian investment partners	7.74M	1.67%	-4.34M
Macquarie group	1.05M	0.02%	-1.20M
Bank of america corp /de/	867.06K	0.00%	-616.95K
Blackrock	1.44M	0.00%	-558.24K
Goldman sachs group	3.72M	0.01%	-491.97K

New Positions

Holder	Shares	% Assets	Change	Value
Cowen and company	530.60K	0.19%	530.60K	$6.87M
Schonfeld strategic advisors	89.40K	0.01%	89.40K	$1.16M
Choreo	22.44K	0.00%	22.44K	$291.57K
Atria investments	21.92K	0.00%	21.92K	$283.68K
Cable hill partners	17.73K	0.03%	17.73K	$234.72K

Sold Out

Holder	Change
Northwest financial advisors	-1.00
West branch capital	-3.00
Ameritas investment partners	-15.00
Sugarloaf wealth management	-15.00
Harbor investment advisory	-24.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	301	5.24%	76,190,360	5.65%	4	23.28%	160	33.33%	85	-16.67%
Jun 30, 2024	285	-10.94%	72,112,827	-7.86%	4	18.47%	120	-25.93%	101	21.69%
Mar 31, 2024	320	2.56%	78,262,422	-6.37%	4	17.57%	162	40.87%	83	-33.60%
Dec 31, 2023	312	-1.58%	83,587,817	3.95%	5	79.64%	115	-21.77%	125	34.41%
Sep 30, 2023	317	-0.31%	80,410,527	-4.27%	2	35.43%	147	8.89%	93	-4.12%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds American Mutual A	12.94M	0.41%	-
Capital Group American Mutual Comp	12.94M	0.41%	-
First Trust Value Line® Dividend ETF	3.19M	0.10%	-1.50K
VanEck Pharmaceutical ETF	2.06M	0.06%	14.95K
Mondrian Int Eq Delivered Strategy	816.00K	0.03%	-1.77M
MAP Global Equity Composite	682.50K	0.02%	-24.46K
ActivePassive International Equity ETF	419.19K	0.01%	1.50K
MAP Global Balanced Composite	380.65K	0.01%	-140.35K
Avantis International Equity ETF	278.63K	0.01%	-
MAP Global Equity Ex-Options Composite	274.11K	0.01%	-16.14K

Insider Transactions Trends

Date	Buy	Sell
2022 Q4	-	-

TAK Ownership FAQ

Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical shareholders are primarily institutional investors at 4.79%, followed by 0.01% insiders and 95.20% retail investors. The average institutional ownership in Takeda Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.23%, which Takeda Pharmaceutical falls below.

Who owns the most shares of Takeda Pharmaceutical?

Takeda Pharmaceutical’s largest shareholders are Capital research global investors (13.13M shares, 0.84%), Mondrian investment partners (7.74M shares, 0.49%), and Morgan stanley (4.99M shares, 0.32%). Together, they hold 1.65% of Takeda Pharmaceutical’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Takeda Pharmaceutical.

Who is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 3.10% of its assets in 1.61M Takeda Pharmaceutical shares, valued at 20.88M$.

Who is the top mutual fund holder of Takeda Pharmaceutical shares?

American Funds American Mutual A is the top mutual fund holder of Takeda Pharmaceutical shares, with 0.41% of its total shares outstanding invested in 12.94M Takeda Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools